Significant New Activities order for Phenacetin
Advocacy & Action
Drug Submission Performance Annual Reports (Fiscal Year 2019-2020)
Determination of the pH of Cosmetics and Similar Consumer Products using the PC-Titrate Instrument (C13.1) Effective: 2020-02-04
Information Sharing – Status of ranitidine drugs in Canada
Update on the AHA/PHA Cosmetic Ingredient Hotlist Entry
Information Session – Notice of Proposal to expand the lists of certain products for distribution as samples
Protection of Canadian Workers from Exposure to Chemicals
Draft Screening Assessment of Alkanolamines and Fatty Alkanolamides Group
Drug and Medical Devices Mid Year Update
DEL Bulletin No. 90 – GUI-0005 Explanatory Notes for Drug Establishment on the Preparation of a Site Master File
